Chemotherapy-induced hair loss;Łysienie wywołane przez chemioterapiȩ przeciwnowotworowa̧

Dermatologia Kliniczna

Volumn 8, Issue 2, 2006, Pages 108-113

  Białynicki Birula, Rafał ^a   Migdał, Ewa ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Katedrze i Klinice Dermatologii Wenerologii i Alergologii   (Poland)

Author keywords

Alopecia; Chemotherapy; Cytostatics; Hair

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; METHOTREXATE; MINOXIDIL;

ALOPECIA; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL ACTIVITY; CELL DAMAGE; CELL PROLIFERATION; DRUG MEGADOSE; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HUMAN; HYPOTHERMIA; METASTASIS; NONHUMAN; REVIEW; RISK FACTOR; SCALP HAIR; SINGLE DRUG DOSE; SKIN DISEASE; TUMOR CELL; UNSPECIFIED SIDE EFFECT;

EID: 33745842623     PISSN: 17307201     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Rubach M., Siedlecki P.: Historia rozwoju chemioterapii nowotworów. [w:] Onkologia kliniczna. red. M. Krzakowski. Borgis, Warszawa, 2001, 15-21.
2. Neisser A.: Zur Erinnerung an den 25-jährigen Bestand der Breslauer Hautklinik 1877 bis 1902. Arch. Dermatol. Syph., 1902, 60, 3-36.
3. Gryglewski R., Korolkiewicz Z.: Leki przecwnowotworowe. [w:] Farmakologia. red. A. Danysz, Z. Kleinorek. PZWL, Warszawa, 1987, 624-645.
4. Orzechowska-Juzwenko K.: Podstawy teoretyczne i ogólne zasady współczesnej chemioterapii nowotworów. [w:] Zarys chemioterapii nowotworów narza̧dowych i układowych. red. K. Orzechowska-Juzwenko. Volumed, Wrocław, 2000, 1-11.
5. Orzechowska-Juzwenko K.: Farmakologia kliniczna leków przeciwnowotworowych. [w:] Zarys chemioterapii nowotworów narza̧dowych i układowych. red. K. Orzechowska-Juzwenko. Volumed, Wrocław, 2000, 13-74.
6. Braun-Falco O., Plewing G., Wolff H.H., Burgdorf W.H.C.: Choroby włosów. [w:] Dematologia. Czelej, Lublin, 2004, 1035-1072.
7. Selleri S., Amabddi F., Vizzotto L., Balsari A., Rumio C.: Epithelium-mesenchyme compartment interaction and oncosts on chemotherapy-induced hair damage. Lab. Invest., 2004, 84, 1404-1417.
8. Seńczuk W.: Zatrucia lekami. [w:] Toksykologia współczesna. PZWL, Warszawa, 2005, 254-310.
9. Wheelock J.B., Myers M.B., Krebs H.B., Goplerud D.R.: Ineffectiveness of scalp hypothermia in the prevention of alopecia in patients treated with doxorubicin and cisplatin combinations. Cancer Treat. Rep., 1984, 68, 1387-1388.
10. Białynicki-Birula R., Baran E.: Leczenie immunosupresyjne w dermatologii. Przewodnik Lekarza, 2002, 37-38, 35-43.
11. Orzechowska-Juzwenko K.: Niepoża̧dane nastȩpstwa chemioterapii nowotworów - sposoby ich zwalczania i zapobiegania. [w:] Zarys chemioterapii nowotworów narza̧dowych i układowych. Volumed, Wrocław, 2000, 351-389.
12. Pai G.S., Vimala A.M., Dinesh M.: Occurrence and severity of alopecia in patients on combination chemotherapy. Indian. J. Cancer., 2000, 37, 95-104.
13. McGarvey E.L., Baum L.D., Pinkerton R.C., Rogers L.M.: Psychological sequelae and alopecia among women with cancer. Cancer Pract., 2001, 9, 283-289.
14. Dollinger M., Rosenbaum E.H., Cable G.: Leczenie skutków niepoża̧danych terapii przeciwnowotworowej. [w:] Uniwersalny przewodnik po metodach leczenia nowotworów. Hannan Publishing Ltd. London, 2000, 147-165.
15. Macduff C., Mackenzie T., Hutcheon A., Melville L., Archibald H.: The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur. J. Cancer Care, 2003, 12, 154-161.
16. Tollenaar R.A., Liefers G.J., Repelaervan Driel O.J., van de Velde C.J.: Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer. Eur. J. Cancer., 1994, 30A, 1448-1453.
17. Elis A., Blickstein D., Manor Y., Lishner M.: Association between alopecia and response to chemotherapy in patients with Hodgkin lymphoma. Ther. Drug. Monit., 2005, 27, 287-289.
18. Katsimbri P., Bamias A., Pavlidis N.: Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur. J. Cancer., 2000, 36, 766-771.
19. Middleton J., Franks D., Buchanan R.B., Hall V., Smallwood J., Williams C.J.: Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine. Cancer Treat. Rep., 1985, 69, 373-375.
20. Trout S., Kemmann E.: Reversible alopecia after single-dose methotrexate treatment in a patient with ectopic pregnancy. Fertil. Steril., 1995, 64, 866-867.
21. Hussein A.M.: Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model. Int. J. Dermatol., 1995, 34, 470-473.
22. Tosti A., Piraccini B.M., Vincenzi C., Misciali C.: Permanent alopecia after busulfan chemotherapy. Br. J. Dermatol., 2005, 152, 1056-1058.
23. Tran D., Sinclair R.D., Schwerer A.P., Chow C.W.: Permanent alopecia following chemotherapy and bone marrow transplantation. Australes. J. Dermatol., 2000, 41, 106-108.
24. Braun-Falco O., Plewing G., Wolff H.H., Burgdorf W.H.C.: Reakcje na leki. [w:] Dermatologia. Czelej, Lublin, 2002, 383-406.
25. Botchkarev V.A.: Molecular mechanisms of chemotherapy-induced hair loss. J. Investig. Dermatol. Symp. Proc., 2003, 8, 72-75.
26. Sharov A.A., Siebenhaar F., Sharova T.Y., Botchkareva N.V., Gilchrest B.A., Botchkarev V.A.: Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res., 2004, 64, 6266-6270.
27. Granai C.O., Frederickson H., Gajewski W., Goodman A., Goldstein A., Baden H.: The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur. J. Gynaecol. Oncol., 1991, 12, 129-132.
28. Bleiker T.O., Nicolaou N., Traulsen J., Hutchinson P.E.: 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Br. J. Dermatol., 2005, 153, 103-112.
29. Kostanecki W.: Łysienia wywołane zatruciami i lekami. [w:] Choroby włosów. red. W. Kostanecki. PZWL, Warszawa, 1970, 114-121.
30. Hesketh P.J., Batchelor D., Golant M., Lyman G.H., Rhodes N., Yardley D.: Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer, 2004, 12, 543-549.
31. Munstedt K., Manthey N., Sachsse S., Vahrson H.: Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer, 1997, 5, 139-143.
32. Randall J., Ream E.: Hair loss with chemotherapy: at a loss over its management? Eur. J. Cancer Care, 2005, 14, 223-231.
33. Samonigg H., Fereberger W., Biffl E.: Pneumatic cold cap for the prevention of doxorubicin-induced alopecia. Wien Med. Wochenschr., 1984, 134, 467-470.
34. Ridderheim M., Bjurberg M., Gustavsson A.: Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer, 2003, 11, 371-377.
35. Ron I.G., Kalmus Y., Kalmus Z., Imbar M., Chaitchik S.: Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer, 1997, 5, 136-138.
36. Dean J.C., Griffith K.S., Cetas T.C., Mackel C.L., Jones S.E., Salmon S.E.: Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia. J. Clin. Oncol., 1983, 1, 33-37.
37. Hanly A.J., Jorda M., Badiavas E., Valencia I., Elgart G.W.: Postoperative pressure-induced alopecia: report of a case and discussion of the role of apoptosis in non-scarring alopecia. J. Cutan. Pathol., 1999, 26, 357-361.
38. Boyer J.D., Vidmar D.A.: Postoperative alopecia: a case report and literature review. Cutis, 1994, 54, 321-322.
39. Janssen F.E., Van Leeuwen G.M., Van Steenhoven A.A.: Modelling of temperature and perfusion during scalp cooling. Phys. Med. Biol., 2005, 50, 4065-4073.
40. Grevelman E.G., Breed W.P.: Prevention of chemotherapy-induced hair loss by scap cooling. Ann. Oncol., 2005, 16, 352-358.
41. Christodoulou C., Klouvas G., Efstathiou E., Zervakis D., Papazachariou E., Plyta M., Skarlos D.V.: Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. Oncology, 2002, 62, 97-102.
42. Massey C.S.: A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. Eur. J. Oncol. Nurs., 2004, 8, 121-130.
43. Perevodchikova N.I., Denisov L.E., Orel N.F., Trofimova N.B., larygin L.M.: Scalp hypothermia as a preventive of alopecia in patients receiving combined chemotherapy including anthracyclines. Vopr. Onkol., 1987, 33, 73-75.
44. Vial J.P., Belloc F., Dumain P., Besnard S., Lacombe F., Boisseau M.R., Reiffers J., Bernard P.: Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk. Res., 1997, 21, 163-172.
45. Vendelbo Jonansen L.: Scalp hypothermia in the prevention of chemotherapy-induced alopecia. Acta Radiol. Oncol., 1985, 24, 113-116.
46. Protiere C., Evans K., Camerio J., d'Ingrado M.P., Macquart-Moulin G., Viens P., Maraninchi D., Genre D.: Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer, 2002, 10, 529-537.
47. Shirai A., Tsunoda H., Tamaoki T., Kamiya T.: Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice. J. Dermatol. Sci., 2001, 27, 7-13.
48. Rodriquez R., Machiavelli M., Leone B., Romero A., Cuevas M.A., Langhi M., Romero Acuna L., Romero Acuna J., Amato S., Barbieri M.: Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia. Ann. Oncol., 1994, 5, 769-770.
49. Duvic M., Lemak N.A., Valero V., Hymes S.R., Farmer K.L., Hortobagyi G.N., Trancik R.J., Bandstra B.A., Compton L.D.: A randomized trial of minoxidil in chemotherapy-induced alopecia. J. Am. Acad. Dermatol., 1996, 35, 74-78.
50. Pandey S., Kekre N., Naderi J., McNulty J.: Induction of apoptotic cell death specifically in rat and human cancer cells by pancratistatin. Artif. Cells Blood Substit. Immobil. Biotechnol., 2005, 33, 279-295.
51. Dierickx C.C.: Epilacja z zastosowaniem promieniowania laserowego lub promieniowania impulsowych, intensywnych źrodeł światła. [w:] Laserowa chirurgia kosmetyczna. red. R.E. Fitzpatrick, M.P. Goldman. Urban&Partner, Wrocław, 2004, 229-254.
52. Walusiak J., Wagrowska-Koski E., Pałczyński C.: Health effects of occupational exposure to cytostatics in medicinal personnel in the light of compulsory prophylactics: a cross-sectional study. Medycyna Praktyczna, 2003, 54, 229-236.
53. Siedlecki P.: Toksyczność cytostatyków dla personelu. [w:] Onkologia kliniczna. red. M. Krzakowski. Borgis, Warszawa, 2001, 534-537.
54. Białynicki-Birula R.: Choroby pȩcherzowe. [w:] Leczenie choro̧b sko̧ry i chorób przenoszonych droga̧ płciowa̧. red. J. Szepietowski. PZWL, Warszawa, 2002, 216-236.
55. Białynicki-Birula R., Kołodziej T.: Choroby tkanki ła̧cznej. [w:] Leczenie chorób skóry i chorób przenoszonych droga̧. płciowa̧. red. J. Szepietowski. PZWL, Warszawa, 2002, 237-264.
56. Baran W., Nockowski P., Białynicki-Birula R.: Współ czesne pogłady na patogenezȩ i leczenie łuszczycy stawowej. Przegl. Dermatol., 2004, 91, 431-436.
57. Reich A., Szepietowski J.: Całkowite wyłysienie i ciȩźka leukopenia z agranulocytoza̧ jako powikłanie leczenia azatiopryna̧ wyprysku kontaktowego dłoni. Dermatol. Klin., 2005, 7, 89-91.
58. Kohno Y.: A case of hair loss induced by carbamazepine. Rhinsho Shinkeigaku, 2004, 44, 379-381.